Inquire About a Product| Product: | Bexarotene-13C4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | C7379 | ||||||||
| Pricing: |
|
||||||||
| Formula: | C2013C4H28O2 | ||||||||
| Enrichment: | 98% 13C | ||||||||
| Molecular Weight: | 352.45 | ||||||||
| Structure: |
|
||||||||
| Category: | Anti-cancer compounds | ||||||||
| Literature References: |
Gniadecki, R; Assaf, C; Bagot, M; Dummer, R; Duvic, M; Knobler, R; Ranki, A; Schwandt, P; Whittaker, S., The optimal use of bexarotene in cutaneous T-cell lymphoma. British Journal of Dermatology, 2007, 157 (3): 433–40.; Dragnev, KH; Petty, WJ; Shah, SJ; Lewis, LD; Black, CC; Memoli, V; Nugent, WC; Hermann, T; Negro-Vilar, A; Rigas, JR; Dmitrovsky, E., A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. Clinical Cancer Research, 2007, 13 (6): 1794–800. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled antineoplastic agent. Used as a treatment for cutaneous T cell lymphoma. A third generation retinoid. |